fecal extract and removed immediately.
with different degrees of disease activity and to study the correlation between fecal LE and other markers of disease activity.
The stability of fecal LE was studied in extracts with LE titers of 32 or higher. LE titers were determined directly and after incubation at 37#{176}C for 24, 48, 72, and 120 h. On the average, LE titers decreased by a factor of 1.4 (range 1-4, n = 24) after 24 h, 1.9 (range 1-4, n = 18) after 48 h, 2.0 (range 1-4, n = 14) after 72 h, and 3.8 (range 1-8, ii = 15) after 120 h ofincubation at 37#{176}C. Thus, the half-life of LE in fecal extracts is -2-3 days. The half-life of lysozyme in similar extracts varied between 0.5 and 3.2 h
(7).
The correlation between fecal LE and fecal lysozyme was studied in 260 extracts of feces obtained from a random population of 140 patients with 
strips.
Because of the instability of lysozyme in the small bowel (7), it is possible to find a high fecal LE titer but a normal lysozyme concentration in patients with small bowel Crohn disease. For example, I measured a fecal LE titer of 2048 but a normal fecal lysozyme concentration in a patient with Crohn disease of the terminal ileum. During medical treatment, this patient's LE titer gradually decreased to 128.
In conclusion, the simple and rapid by some centers, rather than those supplied with the kit, so that some values were closer to the nominal weighed-in concentration (500 p.gfL). For instance, the result for this sample reported by our laboratory, using in-house calibrators prepared independently of the UK Cycle- SP assay, and we intend to revert to the practice of asking participants who are using this assay to indicate the source of their calibrators (2). By recording this information, we should be able to determine whether the change in the relative performance of this assay can be attributed solely to between-method differences in calibration.
